v3.25.2
Fair Value Measurements - Summary of Financial Assets Measured at Fair Value (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2023
Fair Value On Recurring Basis      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total assets   $ 119,786  
Fair Value On Recurring Basis | Level 1      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total assets   34,793  
Fair Value On Recurring Basis | Level 2      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total assets   84,993  
Money Market Funds | Fair Value On Recurring Basis      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Cash Equivalents   34,793  
Money Market Funds | Fair Value On Recurring Basis | Level 1      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Cash Equivalents   34,793  
U.S. Treasury Securities | Fair Value On Recurring Basis      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Marketable Securities   27,004  
U.S. Treasury Securities | Fair Value On Recurring Basis | Level 2      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Marketable Securities   27,004  
Corporate Debt Securities | Fair Value On Recurring Basis      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Marketable Securities   57,989  
Corporate Debt Securities | Fair Value On Recurring Basis | Level 2      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Marketable Securities   57,989  
IKENA ONCOLOGY INC      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Marketable Securities $ 37,352 84,993 $ 55,571
IKENA ONCOLOGY INC | Fair Value On Recurring Basis      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total assets 74,085 119,786 109,184
IKENA ONCOLOGY INC | Fair Value On Recurring Basis | Level 1      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total assets 34,334 34,793 53,613
IKENA ONCOLOGY INC | Fair Value On Recurring Basis | Level 2      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total assets 39,751 84,993 55,571
IKENA ONCOLOGY INC | Money Market Funds | Fair Value On Recurring Basis      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Cash Equivalents 34,334 34,793 53,613
IKENA ONCOLOGY INC | Money Market Funds | Fair Value On Recurring Basis | Level 1      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Cash Equivalents 34,334 34,793 53,613
IKENA ONCOLOGY INC | U.S. Treasury Securities | Fair Value On Recurring Basis      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Marketable Securities   27,004  
IKENA ONCOLOGY INC | U.S. Treasury Securities | Fair Value On Recurring Basis | Level 2      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Marketable Securities   27,004  
IKENA ONCOLOGY INC | Corporate Debt Securities | Fair Value On Recurring Basis      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Cash Equivalents 2,399    
Total Marketable Securities 37,352 57,989 55,571
IKENA ONCOLOGY INC | Corporate Debt Securities | Fair Value On Recurring Basis | Level 2      
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]      
Total Cash Equivalents 2,399    
Total Marketable Securities $ 37,352 $ 57,989 $ 55,571